Viral exploitation and subversion of the immune system through chemokine mimicry.
about
Human herpesvirus 8--a novel human pathogenHuman Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionDiversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesSubversion of cytokine networks by virally encoded decoy receptorsRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersViral Subversion Mechanisms in Chronic Kidney Disease PathogenesisMolecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activityInhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejectionKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replicationModeling HIV quasispecies evolutionary dynamics.Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.Common threads in persistent viral infectionsHerpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors.Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins.Respiratory protein-generated reactive oxygen species as an antimicrobial strategy.Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.Early establishment of gamma-herpesvirus latency: implications for immune control.Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.Immune evasion by Kaposi's sarcoma-associated herpesvirus.Poxvirus immunomodulatory strategies: current perspectivesInteraction of flaviviruses with cells of the vertebrate host and decoy of the immune response.Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function.Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12.Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonistCXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.Viral hijacking of G-protein-coupled-receptor signalling networks.An innately interesting decade of research in immunology.Molecular targets of opiate drug abuse in neuroAIDS.Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity.Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative diseaseHeterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.Down-regulation of cell surface CXCR4 by HIV-1Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.Alphaherpesvirinae and Gammaherpesvirinae glycoprotein L and CMV UL130 originate from chemokinesAn update on Behçet's disease.
P2860
Q24530670-2A5B73F4-69C6-4EB3-9BC8-396EC6BDBF7AQ26751304-8B2E7685-E200-4607-AD05-3F213C93B9ACQ26782778-C7E96968-9C76-4E1B-91D3-0C18D114159AQ27005694-8B8314E3-C26B-4A2C-90FF-E1726F65C936Q27025573-DB7234C2-D25A-41D9-A222-F34FFF28D111Q27485200-41C4D2FE-A9D9-453D-8C04-199B84F3667EQ28302291-19AF70B7-FF8C-4615-ADD4-B02A29D83535Q28752308-D84E5531-43DD-493C-8C78-46B4D9766581Q29394711-C6D7D6E7-5DB0-45A6-BFB0-0B69C120BF41Q30540518-7AA44A74-B581-4A4D-BCF0-8DA2AF58EDF8Q33296550-EBEF65A6-EC35-405D-BF97-B673E55F475FQ33296987-7B5C0232-1864-4E8A-8BCB-4C809CA6C684Q33377026-3E7DF564-F44D-4605-8550-F60855F274CEQ33826650-14EF8C70-BE77-4DFE-AA15-277EB7AC740AQ34332533-E86F2686-9F35-48E5-AE49-33541670E7C0Q34391298-04A31FFD-AB5C-41B9-BBD5-A618DB30E498Q34583194-1B4B4364-4AA5-4D67-B1EE-BD27405D2C3EQ34667659-6702C41F-C7E3-4862-91D1-502CA980FCE2Q34717215-2757916A-E5D3-4C80-8433-822EB662B91AQ34755942-3FC67DCB-2AD2-4A5A-9B80-1011404D6B79Q34776941-2129B4F1-477B-4A63-8A07-6728AB23A5E8Q34795543-FEDB1C0C-5A8C-41F5-AE13-E75BD56629A4Q35125981-E5362589-6379-4140-A78F-CA91423B15DBQ35129744-1AE4204B-FDA4-483E-934A-7EC7CDDBF431Q35209368-A30C087C-1A38-456E-8DCC-459D2D6E5554Q35704720-1F514320-D354-4684-B895-72FC094AEE27Q35748377-A5B05702-EC87-432E-842D-D8984CA288EFQ35847956-21C1763A-BD50-4EE0-AC1E-73EC03975B37Q35964857-99390FBA-5E32-492F-90C6-17457CC174AAQ35968487-6ECCD761-2635-474F-8A85-682733E3A5CFQ35973425-271C4BCE-2DF0-49BD-8E55-A3C247B229E5Q36302053-5C03B47A-0791-4CC5-8BE8-7578C6C18A9FQ36403130-7E294289-2472-415F-B86C-D1A39D4E8412Q36424579-5085B851-B961-4110-859D-6065A29BDF37Q36459685-C2F88558-AD95-4B6D-AD40-81D86FC4B0DCQ36470083-1024A9FD-C0FE-49B4-9F98-248B9158C8B3Q36498115-56699537-A6C2-4B85-854C-6869D49CBEF5Q36539298-A1037905-E9FD-4662-8A75-49799D36F0B0Q36687039-BA2C18CE-45E2-474C-994D-28E8F8CFD8E1Q36701009-C5F503BD-CF83-483A-9EDB-7A4C23C65FBB
P2860
Viral exploitation and subversion of the immune system through chemokine mimicry.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Viral exploitation and subversion of the immune system through chemokine mimicry.
@ast
Viral exploitation and subversion of the immune system through chemokine mimicry.
@en
type
label
Viral exploitation and subversion of the immune system through chemokine mimicry.
@ast
Viral exploitation and subversion of the immune system through chemokine mimicry.
@en
prefLabel
Viral exploitation and subversion of the immune system through chemokine mimicry.
@ast
Viral exploitation and subversion of the immune system through chemokine mimicry.
@en
P2860
P356
P1433
P1476
Viral exploitation and subversion of the immune system through chemokine mimicry.
@en
P2093
P2860
P2888
P304
P356
10.1038/84214
P407
P577
2001-02-01T00:00:00Z
P5875
P6179
1050939486